You are here

Article info

Article menu

Download PDFPDF

Electronic pages
Correspondence response
Response to: ‘Belimumab and the measurement of fatigue’ by Mazzoni
Free

Authors

  1. Correspondence to Dr Vibeke Strand, Division Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California 94028, USA; vstrand{at}aol.com
View Full Text

Citation

Strand V, Levy RA, Cervera R, et al
Response to: ‘Belimumab and the measurement of fatigue’ by Mazzoni
Annals of the Rheumatic Diseases 2015;74:e54.

Publication history

  • Received April 29, 2015
  • Accepted May 1, 2015
  • First published May 19, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions